TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington” February 20, 1981
